B
Broncus Holding Corp
HKEX:2216
Broncus Holding Corp
HKEX:2216
Price:
0.62 HKD
1.64%
Market Closed
Updated:
May 18, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
-11
Current
-8.4
Median
2.5
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=-11
Enterprise Value
/
-883.8m
Revenue
10.3m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| CN |
B
|
Broncus Holding Corp
HKEX:2216
|
326.9m HKD | -11 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
181.1B USD | 4.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.5B USD | 18.7 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.5B USD | 6.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 4.1 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.7B USD | 8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.3B USD | 4.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59B EUR | 3.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
53.7B USD | 8.6 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
52B USD | 13.6 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
373.7B CNY | 9.9 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
-4.5
2-Years Forward
EV/S
-2.8
3-Years Forward
EV/S
N/A
You don't have any saved screeners yet
